Showing results (181-190 of 214) with videos related to

Sort By:
Pageof 22
Biorxiv : the Preprint Server for Biology|April 10, 2023
Anticancer efficacy of KRASG12C inhibitors is potentiated by PAK4 inhibitor KPT9274 in preclinical models of KRASG12C mutant pancreatic and lung cancersHusain Yar Khan, Misako Nagasaka, Amro Aboukameel, et al.
ESMO Open|November 24, 2020
Molecular characteristics of BRCA1/2 and PALB2 mutations in pancreatic ductal adenocarcinomaAndreas Seeber, Kai Zimmer, Florian Kocher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 30, 2019
Molecular Profiling of Appendiceal Adenocarcinoma and Comparison with Right-sided and Left-sided Colorectal CancerRyuma Tokunaga, Joanne Xiu, Curtis Johnston, et al.
European Journal of Cancer (Oxford, England : 1990)|October 20, 2020
The impact of ARID1A mutation on molecular characteristics in colorectal cancerRyuma Tokunaga, Joanne Xiu, Richard M Goldberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2008
Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trialWilliam Small, Jordan Berlin, Gary M Freedman, et al.
Cancer Letters|September 25, 2024
RCC1 regulation of subcellular protein localization via Ran GTPase drives pancreatic ductal adenocarcinoma growthSahar F Bannoura, Amro Aboukameel, Husain Yar Khan, et al.
Oncogene|June 24, 2021
Large-scale analysis of KMT2 mutations defines a distinctive molecular subset with treatment implication in gastric cancerJingyuan Wang, Joanne Xiu, Yasmine Baca, et al.
JAMA Oncology|January 26, 2023
Association of Inflammatory Biomarkers With Survival Among Patients With Stage III Colon CancerEn Cheng, Qian Shi, Anthony F Shields, et al.
The Lancet. Gastroenterology & Hepatology|January 19, 2020
Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 studyPhilip A Philip, Jill Lacy, Fabienne Portales, et al.
Journal of Surgical Oncology|March 14, 2020
Comprehensive tumor profiling reveals unique molecular differences between peritoneal metastases and primary colorectal adenocarcinomaMatthew K Stein, Forrest W Williard, Joanne Xiu, et al.
Pageof 22